Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001178913-14-002992)

Filing Details

Accession Number:
0001178913-14-002992
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-09-22 08:07:28
Reporting Period:
2014-09-21
Filing Date:
2014-09-22
Accepted Time:
2014-09-22 08:07:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158780 Pluristem Therapeutics Inc PSTI Biological Products, (No Disgnostic Substances) (2836) 980351734
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1344740 Zami Aberman 46 Hatapuz St.
Telmond L3 40600		 Ceo & Chairman Yes Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-09-21 2,500 $2.94 1,747,798 No 4 P Direct
Common Stock Acquisiton 2014-09-21 2,500 $2.97 1,750,298 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The purchase was effected on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS) for per share purchase price of NIS 10.72, which per share purchase price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.643 per U.S. dollar.
  2. The purchase was effected on the Tel Aviv Stock Exchange in New Israeli Shekels (NIS) for per share purchase price of NIS 10.83, which per share purchase price has been reported on this Form 4 in U.S. dollars based on an exchange rate of NIS 3.643 per U.S. dollar.